Insider · CIK 0001705564

Enright William

Reports to the SEC for 3 companies · GERMANTOWN, MD

sec.gov

Transactions

Companies

Filings

CIK

0001705564

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-09	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−440K sh	—	—	0
2026-09-09	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−444K sh	—	—	0
2026-09-09	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−360K sh	—	—	0
2026-09-09	BRNSBarinthus Biotherapeutics plc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−728K sh	—	—	0
2026-09-09	BRNSBarinthus Biotherapeutics plc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−515K sh	—	—	0
2026-09-09	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−176K sh	—	—	0
2026-09-09	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−600K sh	—	—	0
2026-06-11	BFRGBullFrog AI Holdings, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2025-09-25	BFRGBullFrog AI Holdings, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2025-08-22	BFRGBullFrog AI Holdings, Inc.A Award	Director	AAward	+2,813 sh	—	—	13,523
2025-08-22	BFRGBullFrog AI Holdings, Inc.A Award	Director	AAward	+5,710 sh	—	—	10,710
2025-02-03	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+600K sh	—	—	600,000
2024-09-26	BFRGBullFrog AI Holdings, Inc. · Stock options (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-01-02	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+444K sh	—	—	443,981
2023-06-14	BFRGBullFrog AI Holdings, Inc.P Purchase	Director	PPurchase	+5,000 sh	$4.05	+$20.3K	5,000
2023-04-16	BFRGBullFrog AI Holdings, Inc. · Stock options (Right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-03-27	BRNSBarinthus Biotherapeutics plc.S Sale	Director, Chief Executive Officer	SSale	−15K sh	$2.42	−$36.3K	728,454
2023-01-03	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+440K sh	—	—	440,000
2022-01-03	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+360K sh	—	—	359,605
2021-05-04	BRNSBarinthus Biotherapeutics plc.A Award	Director, Chief Executive Officer	AAward	+515K sh	—	—	1,258,377
2021-04-29	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+176K sh	—	—	176,130
2021-04-29	BRNSBarinthus Biotherapeutics plc.A Award	Director, Chief Executive Officer	AAward	+456K sh	—	—	1,199,229
2018-05-25	ALTAltimmune, Inc.P Purchase	Director, President and CEO	PPurchase	+1,300 sh	$0.51	+$659.88	365,839
2018-05-21	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director, President and CEO	AAward	+103K sh	—	—	103,158
2018-01-02	ALTAltimmune, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+183K sh	$0.08	+$14.7K	364,511
2018-01-02	ALTAltimmune, Inc. · Stock Options (option to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−183K sh	—	—	0
2017-09-22	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director, President and CEO	AAward	+125K sh	—	—	125,000
2017-08-16	ALTAltimmune, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+91.7K sh	$0.08	+$7,338.64	181,164
2017-08-16	ALTAltimmune, Inc. · Stock Options (option to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−71.6K sh	—	—	0
2017-08-16	ALTAltimmune, Inc. · Stock Options (option to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−91.7K sh	—	—	0
2017-08-16	ALTAltimmune, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+71.6K sh	$0.08	+$5,731.52	89,431
2017-05-04	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director, President and CEO	AAward	+126K sh	—	—	125,887
2017-05-04	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director, President and CEO	AAward	+183K sh	—	—	183,347
2017-05-04	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director, President and CEO	AAward	+91.7K sh	—	—	91,733
2017-05-04	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director, President and CEO	AAward	+71.6K sh	—	—	71,644
2017-05-04	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director, President and CEO	AAward	+99.9K sh	—	—	99,927
2017-05-04	ALTAltimmune, Inc.A Award	Director, President and CEO	AAward	+17.8K sh	—	—	17,787

Recent filings

Accepted (ET)
Sep 94
Enright William0001104659-26-106336
SEC(opens sec.gov)
Jun 154
Enright William0001493152-26-028743
SEC(opens sec.gov)
Sep 294
Enright William0001493152-25-016099
SEC(opens sec.gov)
Aug 264
Enright William0001641172-25-025526
SEC(opens sec.gov)
Feb 125
Enright William0001493152-25-006046
SEC(opens sec.gov)
Feb 54
Enright William0001828185-25-000011
SEC(opens sec.gov)
Jan 44
Enright William0001104659-24-001165
SEC(opens sec.gov)
Jun 154
Enright William0001493152-23-021350
SEC(opens sec.gov)
May 94
Enright William0001493152-23-015995
SEC(opens sec.gov)
Mar 294
Enright William0001104659-23-038357
SEC(opens sec.gov)
Feb 234
Enright William0001104659-23-024802
SEC(opens sec.gov)
Feb 114
Enright William0001104659-22-020821
SEC(opens sec.gov)
May 74/A
Enright William0001104659-21-063196
SEC(opens sec.gov)

Companies

Address

C/O BARINTHUS BIOTHERAPEUTICS PLC 20400 CENTURY BOULEVARD

GERMANTOWN, MD, 20874